Evaluation of hepatocellular carcinoma with computed tomography perfusion imaging
Palma LD. Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 1998; 71: 808–18. Wong R, Frenette C. Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol 2011; 7: 16–24.
Yang L, Zhang XM, Tan BX, Liu M, Dong GL, Zhai ZH. Computed tomographic perfusion imaging for the therapeutic response of chemoembolization for hepatocellular carcinoma. J Comput Assist Tomogr 2012; 36: 226–30.
Koşar PN, Koçak Tufan Z, Ergün E, Yiğit H, Koşar U, Demiröz AP. Chest radiography and computed tomography findings of cases with pandemic influenza A (H1N1/09) infection. Turk J Med Sci 2012; 42: 787–95.
Miles KA. Perfusion CT for the assessment of tumor vascularity: which protocol? Br J Radiol 2003; 76: 36–42. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188: 405–11.
Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist 2008; 13: 120–5.